Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Patient Characteristics and Mortality of Code Blue Calls

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02203435
Recruitment Status : Completed
First Posted : July 29, 2014
Last Update Posted : August 6, 2014
Sponsor:
Information provided by (Responsible Party):
Gulsah Karaoren, Umraniye Education and Research Hospital

Brief Summary:

This study aimed to retrospectively examine patients evaluated by the Code Blue team on a Code Blue call in our hospital between 2009 and 2013.

Primary outcome: an examination of the survival rates and demographic data of the patients evaluated as an emergency by a Code Blue call in the period 2009-2013.Secondary outcome: to determine the rates of false Code Blue calls, the clinics giving Code Blue calls and the relationship between the times of Code Blue calls and mortality.Inclusion criteria: patients throughout the whole hospital for whom a Code Blue form was completed and who were evaluated by the Code Blue team on a Code Blue call.

Exclusion criteria: patients who refused treatment


Condition or disease
Demographics of the Patients Evaluated by Code Blue Call

Detailed Description:
Retrospective examination was made of the Code Blue notification forms which were completed by the anaesthesiologist as Code Blue team leader of the hospital. The age of the patient, gender, diagnosis, the department where admitted, time of Blue Code call, reason for Blue Code call, whether or not the Blue code call was appropriate, whether or not cardiopulmonary resuscitation was administered, if administered, the duration of cardiopulmonary resuscitation, whether or not the patient was postoperative, whether or not the patient had been discharged from the intensive care unit and if so, how many days had passed, the APACHE II score of the patient and expected mortality, were recorded by calculation of the data on thhe Code Blue notification form and in the hospital automated system. Patients were excluded from the study if they had refused treatment or if there was no record of the parameters necessary to calculate the APACHE II score.

Layout table for study information
Study Type : Observational
Actual Enrollment : 1050 participants
Time Perspective: Retrospective
Official Title: The Characteristics of the Blue-code Calls; Five Years Survey.
Study Start Date : January 2014
Actual Primary Completion Date : April 2014
Actual Study Completion Date : April 2014



Primary Outcome Measures :
  1. mortality of blue-codes [ Time Frame: 5 years ]
    an examination of the survival rates and demographic data of the patients evaluated as an emergency by a Code Blue call in the period 2009-2013.


Secondary Outcome Measures :
  1. the demographics of blue code admissions [ Time Frame: 5 years ]
    to determine the rates of false Code Blue calls, the clinics giving Code Blue calls and the relationship between the times of Code Blue calls and mortality.


Other Outcome Measures:
  1. the rate of successful cardiopulmonary resuscitation [ Time Frame: 5 years ]
    the rate of CPR, the apache and saps II expanded values and indication of ICU stay will be calculated



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
This study aimed to retrospectively examine patients evaluated by the Code Blue team on a Code Blue call in our hospital between 2009 and 2013.Retrospective examination was made of the Code Blue notification forms which were completed by the anaesthesiologist as Code Blue team leader of the hospital.
Criteria

Inclusion Criteria:

Patients throughout the whole hospital for whom a Code Blue form was completed and who were evaluated by the Code Blue team on a Code Blue call.

Exclusion Criteria:

Patients who refused treatment

-


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02203435


Locations
Layout table for location information
Turkey
Istanbul Umraniye Education and Research Hospital
Istanbul, Turkey, 34760
Sponsors and Collaborators
Gulsah Karaoren
Investigators
Layout table for investigator information
Study Director: Nurten Bakan, assoc prof Istanbul Umraniye Education and Research Hospital
Publications of Results:
Other Publications:
Layout table for additonal information
Responsible Party: Gulsah Karaoren, doctor, Umraniye Education and Research Hospital
ClinicalTrials.gov Identifier: NCT02203435    
Other Study ID Numbers: GK1
First Posted: July 29, 2014    Key Record Dates
Last Update Posted: August 6, 2014
Last Verified: August 2014
Keywords provided by Gulsah Karaoren, Umraniye Education and Research Hospital:
code blue
Cardiopulmonary Resuscitation
APACHE